Infections from Contaminated Pharmaceuticals or Counterfeit Medications

  • Microbial Contamination in Counterfeit Medications
  • Recent outbreaks of infections from Contaminated pharmaceuticals
  • Microbial cultivable contaminations
  • Potential threats associated with Contaminated Pharmaceuticals
  • Physical or immunological barriers to infection
  • Inconsistent doses of active pharmaceutical
  • Pharmacopoeial limits

Related Conference of Infections from Contaminated Pharmaceuticals or Counterfeit Medications

August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
November 06-07, 2017

3rd International Conference on Flu and Emerging Infectious Diseases

Las Vegas, Nevada, USA
December 07-08, 2017

EuroSciCon Conference on STD-AIDS

Rome, Italy
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 11-12, 2018

4th World Congress on Rare Diseases and Orphan Drugs

Dublin, Ireland
31st August-1st September 2018

International Conference on Emerging Infectious Diseases

Zurich, Switzerland

Infections from Contaminated Pharmaceuticals or Counterfeit Medications Conference Speakers